Power Law company profile

Trillium Therapeutics

Biotech & Life Sciences · Toronto, Canada · Founded 2004 · IPO 2008 Unicorn

Trillium Therapeutics Inc. - Trillium Home

Valuation

$2.26B

Market cap · 2026

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026

Investors

2 investors on Trillium Therapeutics's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Seed 1 investor entered at this stage

Business Development Bank of Canada

Series B+ 1 investor entered at this stage

NEA

Global footprint

Where Trillium Therapeutics has talent and traffic

Workforce by country

2 countries with
team presence

🇨🇦 Canada60%

🇺🇸 United States40%

2 countries shown

Patent intelligence

$14M patent portfolio · 11 active families

Estimated portfolio value

$14M

0.61% of market cap · 38× smaller than top peer ChemoCentryx ($524M)

11 active patent families

Where Trillium Therapeutics innovates DiseaseMolecular biologyCD47Cancer researchPharmaceutical drug

Where Trillium Therapeutics concentrates vs peers

Each axis is a top-10 topic across Trillium Therapeutics and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Trillium Therapeutics

An AI-synthesized read of the highest-engagement posts about Trillium Therapeutics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Trillium Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles